144 related articles for article (PubMed ID: 36918443)
1. Disparities in the Receipt of Recommended Curative Treatment for Patients with Early-Stage Hepatocellular Carcinoma.
Rasic G; de Geus SWL; Papageorge MV; Woods AP; Ng SC; McAneny D; Tseng JF; Sachs TE
World J Surg; 2023 Jul; 47(7):1780-1789. PubMed ID: 36918443
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
3. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
4. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma.
Yu JC; Neugut AI; Wang S; Jacobson JS; Ferrante L; Khungar V; Lim E; Hershman DL; Brown RS; Siegel AB
Cancer; 2010 Apr; 116(7):1801-9. PubMed ID: 20143441
[TBL] [Abstract][Full Text] [Related]
5. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
7. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
Gutin L; Yao F; Dodge JL; Grab J; Mehta N
JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395
[TBL] [Abstract][Full Text] [Related]
9. Association of Sociodemographic Factors with Surgical Management of Hepatoblastoma and Hepatocellular Carcinoma in Children.
Ziogas IA; Roach JP; Acker SN; Corkum KS; Diaz-Miron JL; Kulungowski AM; Gosain A; Hills-Dunlap JL
J Pediatr; 2024 Jun; 269():113963. PubMed ID: 38369237
[TBL] [Abstract][Full Text] [Related]
10. Association of County-Level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment among Patients with Hepatocellular Carcinoma.
Paro A; Dalmacy D; Tslimigras DI; Cloyd J; Ejaz A; Pawlik TM
Ann Surg Oncol; 2022 Aug; 29(8):5177-5185. PubMed ID: 35441305
[TBL] [Abstract][Full Text] [Related]
11. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
[TBL] [Abstract][Full Text] [Related]
12. Differences in Physician Referral Drive Disparities in Surgical Intervention for Hepatocellular Carcinoma: A Retrospective Cohort Study.
Chidi AP; Bryce CL; Myaskovsky L; Fine MJ; Geller DA; Landsittel DP; Tsung A
Ann Surg; 2016 Feb; 263(2):362-8. PubMed ID: 25563883
[TBL] [Abstract][Full Text] [Related]
13. Insurance status impacts treatment for hepatocellular carcinoma.
Sobotka LA; Hinton A; Conteh LF
Ann Hepatol; 2019; 18(3):461-465. PubMed ID: 31040093
[TBL] [Abstract][Full Text] [Related]
14. Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative.
Lee RM; Gamboa AC; Turgeon MK; Yopp A; Ryon EL; Kronenfeld JP; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
Surg Oncol; 2020 Dec; 35():120-125. PubMed ID: 32871546
[TBL] [Abstract][Full Text] [Related]
15. Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma.
Wagle NS; Park S; Washburn D; Ohsfeldt RL; Rich NE; Singal AG; Kum HC
Hepatol Commun; 2022 May; 6(5):1186-1197. PubMed ID: 34796703
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Disparities in Hepatocellular Carcinoma Treatment Receipt in the United States: A Systematic Review and Meta-Analysis.
Wagle NS; Park S; Washburn D; Ohsfeldt R; Kum HC; Singal AG
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):463-470. PubMed ID: 38252039
[TBL] [Abstract][Full Text] [Related]
17. Disparities in treatment and survival in early-stage hepatocellular carcinoma in California.
Gholami S; Kleber KT; Perry LM; Abidalhassan M; McFadden NR; Bateni SB; Maguire FB; Stewart SL; Morris C; Chen M; Gaskill CE; Merkow RP; Keegan TH
J Surg Oncol; 2023 Dec; 128(8):1302-1311. PubMed ID: 37610042
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.
Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M
J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615
[TBL] [Abstract][Full Text] [Related]
19. Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis.
Nathan H; Hyder O; Mayo SC; Hirose K; Wolfgang CL; Choti MA; Pawlik TM
Ann Surg; 2013 Dec; 258(6):1022-7. PubMed ID: 23299519
[TBL] [Abstract][Full Text] [Related]
20. Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma.
Huang DC; Yu RL; Alqahtani S; Tamim H; Saberi B; Bonder A
Ann Hepatol; 2023; 28(5):101127. PubMed ID: 37286167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
